메뉴 건너뛰기




Volumn 12, Issue , 2012, Pages

Salvage chemoradiotherapy after primary chemotherapy for locally advanced pancreatic cancer: A single-institution retrospective analysis

Author keywords

Chemoradiotherapy; Induction chemotherapy; Locally advanced pancreatic cancer; Pancreatic cancer; Prognostic factor; Salvage therapy

Indexed keywords

CA 19-9 ANTIGEN; FLUOROURACIL; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

EID: 84871216064     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-609     Document Type: Article
Times cited : (13)

References (30)
  • 1
    • 0036569654 scopus 로고    scopus 로고
    • Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer
    • 10.1016/S0360-3016(01)02806-1, 12007953
    • Shinchi H, Takao S, Noma H, Matsuo Y, Mataki Y, Mori S, Aikou T. Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2002, 53:146-150. 10.1016/S0360-3016(01)02806-1, 12007953.
    • (2002) Int J Radiat Oncol Biol Phys , vol.53 , pp. 146-150
    • Shinchi, H.1    Takao, S.2    Noma, H.3    Matsuo, Y.4    Mataki, Y.5    Mori, S.6    Aikou, T.7
  • 3
    • 0023722682 scopus 로고
    • Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone
    • Gastrointestinal Tumor Study Group
    • Gastrointestinal Tumor Study Group Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 1988, 80:751-755. Gastrointestinal Tumor Study Group.
    • (1988) J Natl Cancer Inst , vol.80 , pp. 751-755
  • 4
    • 34249790871 scopus 로고    scopus 로고
    • A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer
    • 10.1038/sj.bjc.6603788, 2359907, 17533388
    • Ikeda M, Okusaka T, Ito Y, Ueno H, Morizane C, Furuse J, Ishii H, Kawashima M, Kagami Y, Ikeda H. A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer. Br J Cancer 2007, 96:1650-1655. 10.1038/sj.bjc.6603788, 2359907, 17533388.
    • (2007) Br J Cancer , vol.96 , pp. 1650-1655
    • Ikeda, M.1    Okusaka, T.2    Ito, Y.3    Ueno, H.4    Morizane, C.5    Furuse, J.6    Ishii, H.7    Kawashima, M.8    Kagami, Y.9    Ikeda, H.10
  • 5
    • 0029835349 scopus 로고    scopus 로고
    • Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators
    • 10.1097/00001813-199607000-00010, 8862723
    • Shirasaka T, Shimamato Y, Ohshimo H, Yamaguchi M, Kato T, Yonekura K, Fukushima M. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs 1996, 7:548-557. 10.1097/00001813-199607000-00010, 8862723.
    • (1996) Anticancer Drugs , vol.7 , pp. 548-557
    • Shirasaka, T.1    Shimamato, Y.2    Ohshimo, H.3    Yamaguchi, M.4    Kato, T.5    Yonekura, K.6    Fukushima, M.7
  • 6
    • 58249132914 scopus 로고    scopus 로고
    • Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer
    • 10.1007/s00280-008-0836-1, 18828020
    • Kim HM, Bang S, Park JY, Seong J, Song SY, Chung JB, Park SW. Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer. Cancer Chemother Pharmacol 2009, 63:535-541. 10.1007/s00280-008-0836-1, 18828020.
    • (2009) Cancer Chemother Pharmacol , vol.63 , pp. 535-541
    • Kim, H.M.1    Bang, S.2    Park, J.Y.3    Seong, J.4    Song, S.Y.5    Chung, J.B.6    Park, S.W.7
  • 9
    • 58149467927 scopus 로고    scopus 로고
    • Resectability of pancreatic adenocarcinoma: assessment using multidetector-row computed tomography with multiplanar reformations
    • Manak E, Merkel S, Klein P, Papadopoulos T, Bautz WA, Baum U. Resectability of pancreatic adenocarcinoma: assessment using multidetector-row computed tomography with multiplanar reformations. Abdom Imag 2009, 34:75-80.
    • (2009) Abdom Imag , vol.34 , pp. 75-80
    • Manak, E.1    Merkel, S.2    Klein, P.3    Papadopoulos, T.4    Bautz, W.A.5    Baum, U.6
  • 10
    • 0345505656 scopus 로고    scopus 로고
    • Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma
    • 10.1002/cncr.11165, 12599244
    • Furuse J, Kinoshita T, Kawashima M, Ishii H, Nagase M, Konishi M, Nakagohri T, Inoue K, Ogino T, Ikeda H, Maru Y, Yoshino M. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma. Cancer 2003, 97:1346-1352. 10.1002/cncr.11165, 12599244.
    • (2003) Cancer , vol.97 , pp. 1346-1352
    • Furuse, J.1    Kinoshita, T.2    Kawashima, M.3    Ishii, H.4    Nagase, M.5    Konishi, M.6    Nakagohri, T.7    Inoue, K.8    Ogino, T.9    Ikeda, H.10    Maru, Y.11    Yoshino, M.12
  • 12
    • 34250829023 scopus 로고    scopus 로고
    • Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy
    • 10.1002/cncr.22735, 17538975
    • Krishnan S, Rana V, Janjan NA, Varadhachary GR, Abbruzzese JL, Das P, Delclos ME, Gould MS, Evans DB, Wolff RA, Crane CH. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. Cancer 2007, 110:47-55. 10.1002/cncr.22735, 17538975.
    • (2007) Cancer , vol.110 , pp. 47-55
    • Krishnan, S.1    Rana, V.2    Janjan, N.A.3    Varadhachary, G.R.4    Abbruzzese, J.L.5    Das, P.6    Delclos, M.E.7    Gould, M.S.8    Evans, D.B.9    Wolff, R.A.10    Crane, C.H.11
  • 13
    • 65549143674 scopus 로고    scopus 로고
    • Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review
    • 10.1200/JCO.2008.19.7921, 19307501
    • Huguet F, Girard N, Guerche CS-E, Hennequin C, Mornex F, Azria D. Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review. J Clin Oncol 2009, 27:2269-2277. 10.1200/JCO.2008.19.7921, 19307501.
    • (2009) J Clin Oncol , vol.27 , pp. 2269-2277
    • Huguet, F.1    Girard, N.2    Guerche, C.S.-E.3    Hennequin, C.4    Mornex, F.5    Azria, D.6
  • 14
    • 0030938059 scopus 로고    scopus 로고
    • Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma
    • 10.1002/(SICI)1097-0142(19970415)79:8<1516::AID-CNCR11>3.0.CO;2-0, 9118032
    • Ishii H, Okada S, Tokuuye K, Nose H, Okusaka T, Yoshimori M, Nagahama H, Sumi M, Kagami Y, Ikeda H. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma. Cancer 1997, 79:1516-1520. 10.1002/(SICI)1097-0142(19970415)79:8<1516::AID-CNCR11>3.0.CO;2-0, 9118032.
    • (1997) Cancer , vol.79 , pp. 1516-1520
    • Ishii, H.1    Okada, S.2    Tokuuye, K.3    Nose, H.4    Okusaka, T.5    Yoshimori, M.6    Nagahama, H.7    Sumi, M.8    Kagami, Y.9    Ikeda, H.10
  • 15
    • 77953413803 scopus 로고    scopus 로고
    • Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506
    • 10.1093/jjco/hyq011, 20185458, JCOG Gastrointestinal Oncology Study Group
    • Ishii H, Furuse J, Boku N, Okusaka T, Ikeda M, Ohkawa S, Fukutomi A, Hamamoto Y, Nakamura K, Fukuda H, . JCOG Gastrointestinal Oncology Study Group Phase II study of gemcitabine chemotherapy alone for locally advanced pancreatic carcinoma: JCOG0506. Jpn J Clin Oncol 2010, 40:573-579. 10.1093/jjco/hyq011, 20185458, JCOG Gastrointestinal Oncology Study Group.
    • (2010) Jpn J Clin Oncol , vol.40 , pp. 573-579
    • Ishii, H.1    Furuse, J.2    Boku, N.3    Okusaka, T.4    Ikeda, M.5    Ohkawa, S.6    Fukutomi, A.7    Hamamoto, Y.8    Nakamura, K.9    Fukuda, H.10
  • 17
    • 77954771381 scopus 로고    scopus 로고
    • Chemoradiotherapy versus gemcitabine-based chemotherapy in patients with unresectable, locally advanced pancreatic cancer
    • Nio K, Ueno H, Okusaka T, Morizane C, Hagihara A, Kondo S, Mayahara H, Ito Y. Chemoradiotherapy versus gemcitabine-based chemotherapy in patients with unresectable, locally advanced pancreatic cancer. J Clin Oncol 2010, 28(Suppl):e14504.
    • (2010) J Clin Oncol , vol.28 , Issue.SUPPL
    • Nio, K.1    Ueno, H.2    Okusaka, T.3    Morizane, C.4    Hagihara, A.5    Kondo, S.6    Mayahara, H.7    Ito, Y.8
  • 19
    • 22144444482 scopus 로고    scopus 로고
    • A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: eastern cooperative oncology group study E8282
    • 10.1016/j.ijrobp.2004.12.074, 16029791, Eastern Cooperative Oncology Group
    • Cohen SJ, Dobelbower R, Lipsitz S, Catalano PJ, Sischy B, Smith TJ, Haller DG, Haller DG, . Eastern Cooperative Oncology Group A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: eastern cooperative oncology group study E8282. Int J Radiat Oncol Biol Phys 2005, 62:1345-1350. 10.1016/j.ijrobp.2004.12.074, 16029791, Eastern Cooperative Oncology Group.
    • (2005) Int J Radiat Oncol Biol Phys , vol.62 , pp. 1345-1350
    • Cohen, S.J.1    Dobelbower, R.2    Lipsitz, S.3    Catalano, P.J.4    Sischy, B.5    Smith, T.J.6    Haller, D.G.7    Haller, D.G.8
  • 20
    • 80755143456 scopus 로고    scopus 로고
    • Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an eastern cooperative oncology group trial
    • 10.1200/JCO.2011.34.8904, 3525836, 21969502
    • Loehrer PJ, Feng Y, Cardenes H, Wagner L, Brell JM, Cella D, Flynn P, Ramanathan RK, Crane CH, Alberts SR, Benson AB. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an eastern cooperative oncology group trial. J Clin Oncol 2011, 29:4105-4111. 10.1200/JCO.2011.34.8904, 3525836, 21969502.
    • (2011) J Clin Oncol , vol.29 , pp. 4105-4111
    • Loehrer, P.J.1    Feng, Y.2    Cardenes, H.3    Wagner, L.4    Brell, J.M.5    Cella, D.6    Flynn, P.7    Ramanathan, R.K.8    Crane, C.H.9    Alberts, S.R.10    Benson, A.B.11
  • 21
    • 80053372502 scopus 로고    scopus 로고
    • A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier oncology group study
    • 10.1097/COC.0b013e3181e9c103, 20881474
    • Cardenes HR, Moore AM, Johnson CS, Yu M, Helft P, Chiorean EG, Vinson J, Howard TJ, Stephens AW, Tai DF, Loehrer PJ. A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier oncology group study. Am J Clin Oncol 2011, 34:460-465. 10.1097/COC.0b013e3181e9c103, 20881474.
    • (2011) Am J Clin Oncol , vol.34 , pp. 460-465
    • Cardenes, H.R.1    Moore, A.M.2    Johnson, C.S.3    Yu, M.4    Helft, P.5    Chiorean, E.G.6    Vinson, J.7    Howard, T.J.8    Stephens, A.W.9    Tai, D.F.10    Loehrer, P.J.11
  • 22
    • 33749169384 scopus 로고    scopus 로고
    • S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU
    • Nakata E, Fukushima M, Takai Y, Nemoto K, Ogawa Y, Nomiya T, Nakamura Y, Milas L, Yamada S. S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU. Oncol Rep 2006, 16:465-471.
    • (2006) Oncol Rep , vol.16 , pp. 465-471
    • Nakata, E.1    Fukushima, M.2    Takai, Y.3    Nemoto, K.4    Ogawa, Y.5    Nomiya, T.6    Nakamura, Y.7    Milas, L.8    Yamada, S.9
  • 26
    • 41949089709 scopus 로고    scopus 로고
    • Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a groupe coordinateur multidisciplinaire en O
    • 10.1200/JCO.2007.12.8223, 18309942
    • Moureau-Zabotto L, Phélip JM, Afchain P, Mineur L, André T, Vendrely V, Lledo G, Dupuis O, Huguet F, Touboul E, Balosso J, Louvet C. Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a groupe coordinateur multidisciplinaire en O. J Clin Oncol 2008, 26:1080-1085. 10.1200/JCO.2007.12.8223, 18309942.
    • (2008) J Clin Oncol , vol.26 , pp. 1080-1085
    • Moureau-Zabotto, L.1    Phélip, J.M.2    Afchain, P.3    Mineur, L.4    André, T.5    Vendrely, V.6    Lledo, G.7    Dupuis, O.8    Huguet, F.9    Touboul, E.10    Balosso, J.11    Louvet, C.12
  • 27
    • 77954665310 scopus 로고    scopus 로고
    • A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer
    • 10.1007/s00280-009-1193-4, 19967537
    • Nakachi K, Furuse J, Kinoshita T, Kawashima M, Ishii H, Ikeda M, Mitsunaga S, Shimizu S. A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer. Cancer Chemother Pharmacol 2010, 66:527-534. 10.1007/s00280-009-1193-4, 19967537.
    • (2010) Cancer Chemother Pharmacol , vol.66 , pp. 527-534
    • Nakachi, K.1    Furuse, J.2    Kinoshita, T.3    Kawashima, M.4    Ishii, H.5    Ikeda, M.6    Mitsunaga, S.7    Shimizu, S.8
  • 28
    • 80051613675 scopus 로고    scopus 로고
    • Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4 (Dpc4) immunostaining with pattern of disease progression
    • 10.1200/JCO.2010.33.8038, 3157965, 21709185
    • Crane CH, Varadhachary GR, Yordy JS, Staerkel GA, Javle MM, Safran H, Haque W, Hobbs BD, Krishnan S, Fleming JB, Das P, Lee JE, Abbruzzese JL, Wolff RA. Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4 (Dpc4) immunostaining with pattern of disease progression. J Clin Oncol 2011, 29:3037-3043. 10.1200/JCO.2010.33.8038, 3157965, 21709185.
    • (2011) J Clin Oncol , vol.29 , pp. 3037-3043
    • Crane, C.H.1    Varadhachary, G.R.2    Yordy, J.S.3    Staerkel, G.A.4    Javle, M.M.5    Safran, H.6    Haque, W.7    Hobbs, B.D.8    Krishnan, S.9    Fleming, J.B.10    Das, P.11    Lee, J.E.12    Abbruzzese, J.L.13    Wolff, R.A.14
  • 30
    • 61349202170 scopus 로고    scopus 로고
    • CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy
    • 10.1016/j.ijrobp.2008.06.1483, 18760544
    • Koom WS, Seong J, Kim YB, Pyun HO, Song SY. CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys 2009, 73:1148-1154. 10.1016/j.ijrobp.2008.06.1483, 18760544.
    • (2009) Int J Radiat Oncol Biol Phys , vol.73 , pp. 1148-1154
    • Koom, W.S.1    Seong, J.2    Kim, Y.B.3    Pyun, H.O.4    Song, S.Y.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.